search
Back to results

Appropriate Gestational Weight Gain in Overweight/Obese Women

Primary Purpose

Gestational Weight Gain

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Lifestyle Intervention
Usual Care
Sponsored by
Kaiser Permanente
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Gestational Weight Gain focused on measuring Gestational weight gain, Lifestyle, Intervention

Eligibility Criteria

18 Years - 45 Years (Adult)FemaleDoes not accept healthy volunteers

Inclusion Criteria:

  • Pregnant
  • Pregravid BMI 25 to <40 (as determined from a measured pregravid weight in electronic medical record)

Exclusion Criteria:

  • Diabetes
  • Cardiovascular disease
  • Gastrointestinal disease
  • Bariatric surgery
  • Lung disease
  • Thyroid disease
  • Eating disorder
  • Cancer
  • Bed rest or Gestational Diabetes in the current pregnancy
  • Planning to get pregnant again or move within 1 year of delivery
  • Substance abuse
  • Serious mental health disorders

Sites / Locations

  • Kaiser Permanente Oakland Medical Center
  • Kaiser Permanente Santa Clara Medical Center

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Lifestyle Intervention

Usual Care

Arm Description

The goal of the intervention is to help women achieve the lower bound of the GWG range recommended by the Institutes of Medicine (IOM) for a given prepregnancy BMI category (i.e., 11 lbs for obese women and 15 lbs for overweight women). The pregnancy lifestyle intervention will be delivered by trained study dieticians via individual counseling sessions: 2 in-person and 11 telephone sessions delivered on a weekly basis, followed by telephone sessions delivered every other week through the end of pregnancy.

Usual Medical Care

Outcomes

Primary Outcome Measures

Rate of gestational weight gain per week
Proportion of women exceeding the Institute of Medicine's recommendation for rate of gestational weight gain per week

Secondary Outcome Measures

Total gestational weight gain
Proportion of women exceeding the Institute of Medicine's recommendation for total gestational weight gain per week
Rate of gestational weight gain between study clinical assessments
Diet - total calories from fat
Diet - proportion of calories from fat
Physical Activity
Metabolic marker - glycemia
Metabolic marker - insulinemia
Metabolic marker - lipids
Metabolic marker - leptin
Metabolic marker - adiponectin

Full Information

First Posted
April 30, 2014
Last Updated
April 3, 2020
Sponsor
Kaiser Permanente
Collaborators
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
search

1. Study Identification

Unique Protocol Identification Number
NCT02130232
Brief Title
Appropriate Gestational Weight Gain in Overweight/Obese Women
Official Title
Appropriate Gestational Weight Gain in Overweight/Obese Women
Study Type
Interventional

2. Study Status

Record Verification Date
April 2020
Overall Recruitment Status
Completed
Study Start Date
April 2014 (undefined)
Primary Completion Date
February 2019 (Actual)
Study Completion Date
February 2020 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Kaiser Permanente
Collaborators
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The goal of this trial is to investigate the efficacy of a lifestyle intervention of healthy diet and physical activity for helping overweight/obese pregnant women to achieve appropriate gestational weight gain (GWG) for their prepregnancy body mass index (BMI). The goal of the intervention is to help women achieve the lower bound of the GWG range recommended by the Institutes of Medicine (IOM) for a given prepregnancy BMI category (i.e., 11 lbs for obese women and 15 lbs for overweight women). The lifestyle intervention will be delivered via 2 in-person counseling sessions and 11 telephone contacts with study dieticians trained in motivational interviewing techniques. The lifestyle intervention will be compared to usual medical care. Outcomes will be assessed by trained study personnel at approximately 10 weeks and 32 weeks gestation, within several days of delivery and at 6 months and 12 months postpartum.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Gestational Weight Gain
Keywords
Gestational weight gain, Lifestyle, Intervention

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Care ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
398 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Lifestyle Intervention
Arm Type
Experimental
Arm Description
The goal of the intervention is to help women achieve the lower bound of the GWG range recommended by the Institutes of Medicine (IOM) for a given prepregnancy BMI category (i.e., 11 lbs for obese women and 15 lbs for overweight women). The pregnancy lifestyle intervention will be delivered by trained study dieticians via individual counseling sessions: 2 in-person and 11 telephone sessions delivered on a weekly basis, followed by telephone sessions delivered every other week through the end of pregnancy.
Arm Title
Usual Care
Arm Type
Active Comparator
Arm Description
Usual Medical Care
Intervention Type
Behavioral
Intervention Name(s)
Lifestyle Intervention
Intervention Type
Other
Intervention Name(s)
Usual Care
Primary Outcome Measure Information:
Title
Rate of gestational weight gain per week
Time Frame
From pre-pregnancy weight to last pregnancy weight up to 21 weeks to 42 weeks of pregnancy
Title
Proportion of women exceeding the Institute of Medicine's recommendation for rate of gestational weight gain per week
Time Frame
from pre-pregnancy weight up to 21 weeks to 42 weeks of pregnancy
Secondary Outcome Measure Information:
Title
Total gestational weight gain
Time Frame
from pre-pregnancy weight to last pregnancy weight up to 24 weeks to 42 weeks
Title
Proportion of women exceeding the Institute of Medicine's recommendation for total gestational weight gain per week
Time Frame
From pre-pregnancy weight to last pregnancy weight up to 24 weeks to 42 weeks
Title
Rate of gestational weight gain between study clinical assessments
Time Frame
Rate of gestational weight gain between approximately 10 weeks and 32 weeks gestation (kilograms per week)
Title
Diet - total calories from fat
Time Frame
Change in total calories from fat between study clinical assessments in pregnancy between 10 weeks and 32 weeks gestation
Title
Diet - proportion of calories from fat
Time Frame
Change in proportion of calories from fat between study clinical assessments in pregnancy between 10 weeks and 32 weeks gestation
Title
Physical Activity
Time Frame
Change in physical activity between study clinical assessments in pregnancy (i.e., between 10 weeks and 32 weeks gestation, approximately)
Title
Metabolic marker - glycemia
Time Frame
Change in glucose between study clinical assessments in pregnancy (i.e., between 10 weeks and 32 weeks gestation, approximately)
Title
Metabolic marker - insulinemia
Time Frame
Change in insulin between study clinical assessments in pregnancy (i.e., between 10 weeks and 32 weeks gestation, approximately)
Title
Metabolic marker - lipids
Time Frame
Change in lipids between study clinical assessments in pregnancy (i.e., between 10 weeks and 32 weeks gestation, approximately)
Title
Metabolic marker - leptin
Time Frame
Change in leptin between study clinical assessments in pregnancy (i.e., between 10 weeks and 32 weeks gestation, approximately)
Title
Metabolic marker - adiponectin
Time Frame
Change in adiponectin between study clinical assessments in pregnancy (i.e., between 10 weeks and 32 weeks gestation, approximately)

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
45 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Pregnant Pregravid BMI 25 to <40 (as determined from a measured pregravid weight in electronic medical record) Exclusion Criteria: Diabetes Cardiovascular disease Gastrointestinal disease Bariatric surgery Lung disease Thyroid disease Eating disorder Cancer Bed rest or Gestational Diabetes in the current pregnancy Planning to get pregnant again or move within 1 year of delivery Substance abuse Serious mental health disorders
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Assiamira Ferrara, MD PhD
Organizational Affiliation
Kaiser Permanente Division of Research
Official's Role
Principal Investigator
Facility Information:
Facility Name
Kaiser Permanente Oakland Medical Center
City
Oakland
State/Province
California
ZIP/Postal Code
94611
Country
United States
Facility Name
Kaiser Permanente Santa Clara Medical Center
City
Santa Clara
State/Province
California
ZIP/Postal Code
95051
Country
United States

12. IPD Sharing Statement

Citations:
PubMed Identifier
34544560
Citation
Jake-Schoffman DE, Brown SD, Baiocchi M, Bibeau JL, Daubenmier J, Ferrara A, Galarce MN, Hartogensis W, Hecht FM, Hedderson MM, Moran PJ, Pagoto SL, Tsai AL, Waring ME, Kiernan M. Methods-Motivational Interviewing Approach for Enhanced Retention and Attendance. Am J Prev Med. 2021 Oct;61(4):606-617. doi: 10.1016/j.amepre.2021.04.005.
Results Reference
derived
PubMed Identifier
32445736
Citation
Ferrara A, Hedderson MM, Brown SD, Ehrlich SF, Tsai AL, Feng J, Galarce M, Marcovina S, Catalano P, Quesenberry CP. A telehealth lifestyle intervention to reduce excess gestational weight gain in pregnant women with overweight or obesity (GLOW): a randomised, parallel-group, controlled trial. Lancet Diabetes Endocrinol. 2020 Jun;8(6):490-500. doi: 10.1016/S2213-8587(20)30107-8. Erratum In: Lancet Diabetes Endocrinol. 2023 Apr;11(4):e6.
Results Reference
derived
PubMed Identifier
31039753
Citation
Brown SD, Hedderson MM, Ehrlich SF, Galarce MN, Tsai AL, Quesenberry CP, Ferrara A. Gestational weight gain and optimal wellness (GLOW): rationale and methods for a randomized controlled trial of a lifestyle intervention among pregnant women with overweight or obesity. BMC Pregnancy Childbirth. 2019 Apr 30;19(1):145. doi: 10.1186/s12884-019-2293-8.
Results Reference
derived

Learn more about this trial

Appropriate Gestational Weight Gain in Overweight/Obese Women

We'll reach out to this number within 24 hrs